A B S T R A C T Continuous infusions of A'-androstenedione-7-8H and testosterone-7-3H have been used to demonstrate that these androgens are converted to estrone and 17p-estradiol, and contribute to the circulating blood levels of these estrogens in normal males and females. The conversion ratio (ratio of concentrations of radioactivity of free product steroid [LPRO] Studies on the distribution coefficients (effective concentration in red cells/plasma) for precursor radioactivity were also made.
INTRODUCTION
In vivo studies in humans using isotopically labeled A'-androstenedione and testosterone have shown that interconversions occur between these steroids, both of which are secreted (1, 2) . The contribution of the chemical product of these interconversions to the blood pool of free steroid is less than the contribution to the pool of steroid metabolites appearing in the urine. Thus, measurement of production and secretion rates from analysis of urinary metabolites can lead to erroneous conclusions about blood production and secretion rates METHODS Normal adult volunteers were infused with testosterone-7a-'H or A'-androstenedione-7a-'H. The adults were 21-40 yr of age, had given informed consent, and were in excellent health taking no medication. All the females infused were in the follicular phase of the menstrual cycle.
The solvents used for extraction of plasma samples and for chromatography were of spectral quality. Pyridine, acetic anhydride, and pipsyl chloride were obtained and purified as described (7, 13) .
Testosterone-7a-'H (SA 10.0 c/mmole) and A'-androstenedione-7a-%H (1.0 c/mmole), obtained from Nuclear Chicago Corporation, Des Plaines, Ill. and testosterone4-1'C (50 mc/mmole) and A'-androstenedione-4-A4C (50 mc/mmole) obtained from New England Nuclear Corp., Boston, Mass.
were purified by column chromatography (2) . 17,f-Estradiol- 4 -J'C (31.7 mc/mmole) and estrone--'C (33.7 mc/mmole) were obtained from Nuclear Chicago Corp. and purified by column and paper chromatography as described (7) .
The paper chromatography of samples was carried out using Whatman 2 paper in the following systems:
P-1 stationary phase, methanol: water, 85: 15 mobile phase, Skellysolve C P-2 stationary phase, methanol water, 90: 10 mobile phase, hexane P-3 stationary phase, methanol water, 90:10 mobile phase, isooctane PA stationary phase, water 90: 10 mobile phase, ligroin Thin-layer chromatography (TLC) was carried out using Neutral Alumina GF254 (E. Merck, A. G., Darmstadt, Germany), Silica Gel HF254 or GF254 (Brinkmann Instruments, Inc., Great Neck, N. Y.) in the following systems:
C-1 benzene: ethyl acetate, 2. :1 C-2 chloroform: acetone, 89: 11 C-3 chloroform acetone, 92: 8 CA chloroform: acetone, 98: 2 C-5 cyclohexane: ethyl acetate, 75: 25 C-6 chloroform: methanol: 1 N-NaOH, 9: 2.11 C-7 benzene: methanol, 98: 2 C-8 benzene: ethanol, 98: 2 C-9 cyclohexane: ethyl acetate, 75: 50. All experiments were started between 8 and 9 a.m., with the subjects fasting and in the supine position 1 hr before the loading dose was administered. At zero time an injection of either 4-6 ac of androstenedione-7a-H or testosterone7a-'H in 10 ml isotonic saline was given into an arm vein. 30 min later, an infusion of the same steroid was begun and continued a constant rate for 120 min. The infusion consisted of 10-30 pc of the 'H-labeled steroid in 50 ml of an 8% ethanolic solution of normal saline administered through Teflon tubing (Becton-Dicdkinson & Co., Rutherford, N. J.) so that absorption was negligible. Samples were taken from both the stock solution and from the infusion tubing for calculation of radioactivity infused (14) .
Blood samples of 50-60 cc were obtained at 120, 135, and 150 min after the loading dose and were drawn into hepannized syringes from the opposite arm vein. Blood was centrifuged and the plasma extracted immediately or frozen at -20'C until extracted.
Analysis of plasma. The plasma was added to a flask containing androstenedione-4-C (350 dpm), testosterone-4-1C (350 dpm), estrone-4-j'C (140 dpm), and estradiol4.UC (140 dpm) and 50 pg each of the following nonradioactive steroids: androstenedione, testosterone, estrone, and estradiol. To this was added 0.5 ml 4 N NaOH; the contents were then swirled and extracted with three volumes and then two volumes of anhydrous ether (2) . The ether extracts were pooled and washed twice with 10-ml volumes of distilled water. The ether was removed under vacuum and the residue transferred to a stoppered tube with three 2 ml volumes of 70% methanol. 12 ml of petroleum ether (bp 75.8-96.4'C) was added, the tube was shaken, centrifuged, and the petroleum ether removed and discarded. The aqueous methanol was removed under vacuum and the residue taken up in 4 ml benzene and partitioned against 20 ml 1 N NaOH. The tube was centrifuged and the benzene fraction containing the androgens removed. To the 1 N NaOH was added another 1 ml benzene, the tube was shaken, centrifuged, and the benzene removed and pooled. The benzene fraction containing the androgens and the NaOH fraction containing the estrogens were separately treated as described. Benzene fraction (androgens). The benzene was removed, the residue taken up in S ml dichloromethane (CH2CL,) and washed with 1.5 ml 0.1 M acetic acid and then with two 1 ml volumes of H20. The CHsCls was removed under vacuum and the residue run on alumina TLC in system C-1. The androstenedione and testosterone spots, located using 254 mni UV light, were separately eluted as described (2) . The dried samples containing androstenedione and testosterone from TLC C-1 were spotted on paper and run in system P-i. The steroids again were located with UV light at 254 mp, and the appropriate areas were eluted into counting vials, and the vials dried, and counted as described (15) . Recoveries through the procedure were 3045% for' androstenedione and 45-65% for testosterone.
NaOH extracts (estrogens). The NaOH extracts were brought to pH 7 with glacial acetic acid and extracted twice with 50 ml of anhydrous ether. The ether extracts were washed twice with 10 ml of H20, and dried, and run in parallel with nonradioactive estrone and 17p-estradiol on Silica Gel HFmu in system C-a The carrier estrogens were located and eluted as described (7) . After elution, the tube containing estradiol was dried and the residue rerun on Silica Gel HFEM in system C-6. The carrier estrogen was located and eluted, and the tubes containing estradiol from C-6 and estrone from C-2 were dried and the contents acetylated overnight (7) . Under these conditions, estrone was converted into estrone 3-acetate and estradiol was converted into estradiol-3-monoacetate. Estrone acetate was then chromatographed on Silica Gel HFm in two dimensions in system C4. Estradiol 3-monoacetate was chromatographed on Silica Gel HFu in two dimension using systems C-3 and then C-7. The steroids were located and eluted into counting vials. These were dried and 10 ml of scintillation fluid (84 ml Liquifluor [Pilot Chemicals, Inc., Watertown, Mass.], 20 ml of ethanol, and 1 liter of toluene) were added to each vial. The vials were counted for 10 X 40 min. Using a treatment similar to that described by Horton -and Tait (15) , it was possible to calculate maximal counting errors. For the determination of the concentration of radioactivity in the estrone from androstenedione in both sexes and in the estradiol from testosterone in males the maximal counting errors were 10%, and in the estradiol from testosterone in females the maximal counting errors were 25%.
The recoveries from plasma through the entire purification were 35-50% for estrone4-1C and 40-60% for estradiol-4-C.
Analysis of whole blood. In certain experiments, a 10 cc aliquot of whole blood was removed before centrifugation.
Androstenedione4-1C (350 dpm) and testosterone4.1C
(350 dpm) were added to this aliquot which was laked with water and extracted with three and two volumes of ether. The ether extracts were pooled and analyzed as described above for the concentration of androstenedione-14C and -'H and testosterone-J4C and -'H. Radiochemical purity of recovered steroids. The radiochemical purity of the recovered androstenedione and testosterone has already been demonstrated (2) .
The following methods were used to establish the radiochemical purity of the recovered estrone. (a) After an infusion of androstenedione, using three times the usual amount of androstenedione-'H, blood was drawn at the usual time intervals, and the plasma with 14C indicator and carrier steroids were pooled and extracted as usual. The estrone fraction was carried through the usual chromatography steps, and, after the two-dimensional TLC of estrone acetate, onethird was taken for counting. The remaining two-thirds was reduced with sodium borohydride (7) (b) After a similar infusion of androstenedione, plasma samples were pooled and extracted as usual. The estrone fraction was carried through the usual chromatography steps and after the two-dimensional TLC of estrone acetate, onethird was taken for counting. The remainder was reduced with sodium borohydride and the resultant estradiol 3-monoacetate was spotted on Silica Gel HFm and run in two dimensions using system C-3 and C-7. The area corresponding to authentic estradiol 3-monoacetate was eluted and acetylated overnight with pyridine, 0.1 ml, and 10% acetic anhydride in benzene, 0.1 ml The reaction was stopped with 0.05 ml ethanol, and the resulting estradiol diacetate was chromatographed on Silica Gels in system C-S. The area corresponding to authentic estradiol diacetate was eluted into a counting vial and counted. The "H: "C ratio of the estrone acetate was 0.96 ±0.19 and of the estradiol diacetate was 1.09 *020. The similarity of the "H: 'C ratio In these two experiments indicates hat a high degree of radiochemical purity results from the routine purFication procedure.
For the demosration of radio ical purity of the recovered estradiol, the following wa done. (a) After an infusion of testosterone-8H (T-'H), using twice the usual amount of T-'H, blood was drawn at 120, 135, and 150 min, and the plasma volumes with indicator and carrier were pooled and excted The estradiol fraction was carried through the usual chromatographic steps and after the two-dimensional TLC of estradiol 3-monoacetate, one-third was taken for couting. The raining two-thirds was acetylated overnight with 0.1 ml pyridine and 0.1 ml 10% acetic anhydride in benzene. The reaction was stopped with 0.1 ml ethanol. The tube was dried and the residue spotted on Silica Gel HFs.
and run in system C-5. The estradiol diacetate spot was located under 254 m WUV light, eluted into a counting vial, and counted. The "H: "C ratios of the estradiol 3-monoacetate and estradiol diacetate were 0 22 :0.02 and 0.23 ±0.01, respectively.
(b) After another infusion of testosterone-MH, three times the usual amount, the pooled plasma recovered from the three blood samples was extracted. The estradiol fraction was analyzed and after the two-dimensional TLC, one-third of the resultant estradiol 3-monoacetate was counted. The remaining two-thirds were chromatographed in paper system P-2. Standards were run along with the sample and sprayed with 10% phosphomolybdic acid in methanol to locate the steroids. The area corresponding to authentic estradiol 3-monoacetate was recovered and eluted into a tube. The tube was dried and the residue was acetylated overnight in the dark with 0.1 ml pyridine and 0.1 ml 10% acetic anhydride in benzene. The reaction was stopped with 0.1 ml ethanol, the tube was dried, and the residue was spotted on Silica Gel HF.. and run in system C-5. The estradiol diacetate was located as usual, eluted, and counted. The 'H: TC ratios of the estradiol 3-monoacetate and estradiol diacetate were 0.43 ± 0.02 and 0.45 ±0.01, respectively.
(c) After a 3rd infusion of testosterone, using three times the usual amount, the pooled plasma from the three blood samples was extracted. After the 2nd TLC of the estradiol fraction, a portion was taken, acetylated to form estradiol 3-monoacetate, chromatographed as usual in two dimensions, and counted. The remainder of the estradiol was dried and dissolved in a solution of 25 /Al acetone, 25 Ad H2O, and 25 jul 0.1 N NaOH (13) . While shaking, 0 2 mg pipsyl chloride in 25 #1 acetone was added to this. The sides of the tube were washed with 25 Id acetone, and the tube was shaken for 30 min at room temperature. Then, 0.4 ml chloroform was added and washed three times with 025 ml volumes of H20. The tube was dried under N2, the residue spotted with carrier on Silica Gel GF., and run in two dimensions in systems C-9 and C-8. The estradiol 3-monopipsylate was located with 254 mA UV light and eluted. The monopipsylate was then spotted on paper and run in system P4. It was then eluted and respotted on paper. To the spot was added 2 drops of 5% chromic acid in water to form estronemonopipsylate. The paper was dried in air for 10 min and then run in system P-3. The estrone-monopipsylate was reduced using sodium borohydride, and the resultant estradiol 3-monopipsylate was acetylated overnight with 0.3 ml pyridine and 0.15 ml acetic anhydride. The tube was dried under vacuum, the residue spotted on Silica Gel GF=, and run in system C-5. The steroid was located with 254 mp UV light, eluted, and counted. The 'H: "C ratios of the estradiol 3-monoacetate and estradiol 3-monopipsylate-17-monoacetate were 0.38 ±0.01 and 0.42 ±0.05. The stability of the 'H: 'C ratio through various derivatives and chronatographies indicate the rademical purt of the estradiol-'H recovered after testosterone-H infuion.
Proof tht a steady state has been reached for rdoactivaty as the precursor and product steroids. It has been shown (2) that under similar conditions of infusion, the concentrations of radioactivity as testosterone and AW-androstenedione, whether as precursor of product, have reached a steady state.
When estrone is the product, and the concentration of radioactivity as estrone in the 135 mm sample is set at 100%, the concentration of radioactivity at 120 min and 150 mm are 92 ±5% (statistical counting error) and 101 ±3% of this value. Neither of these differ significantly from 100% (P > 0.05).
Similarly, when the concentration of radioactivity as estradiol at 135 min is set at 100%, the concentrations at 120 min and 150 min are 87 ±10% and 103 ± 22% of this value.
Neither of these differ significantly from 100%o (P > 0.05).
It has been reported (7) that when estrone-'H or estradiol-PH are administered under similar conditions of infusion the concentrations of radioactivity in both precursor and product estrogen reach a steady state within 2 hr. In addition when estrone-'H or estradiol-'H are administered under conditions similar to that described in the present paper but for infusion periods ranging from 6 to 12 hr, the concentrations of radioactivity in the blood do not vary significantly after normal distribution. However, functions of a normal distribution are normally distributed (20) , and since the sum of two normal distributions has a normal distribution (21) Tables I  and II are listed the concentrations (counts per minute per liter), corrected for recoveries, of androgen precursor and estrogen product. When androstenedione-8H was infused as precursor, estrone-MH was always re--covered as product. In only three instances, subjects 6, 13, and 15, were we able to recover 'H-labeled estradiol. In these three subjects, the amounts of radioactivity infused had been two to three times greater (40-50 uc/2 hr) than the usual amounts infused. The mean values for estradiol were, respectively, 160, 100, and 120 cpm/liter.
When testosterone-'H was infused as precursor, estradiol-MH was always recovered as product. In only two instances, subjects 4 and 6, was estrone-MH recovered as product. In these two subjects, the amounts of radioactivity infused had been roughly two times (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) Ic/2 hr) more than the usual, and the mean values for estrone-'H were 50 and 120 cpm/liter, respectively.
Conversion ratios (CRIB = mean ±+[SEM]) for androgen conversion to estrogen. In nine males, the mean C16B3 A was 0.013 ±0.0024 (SEM), and in six females, the mean CRBB Al was 0.0069 ±0.0007 (Table I) . CRBBAID was 0.002 in the one male in whom it was possible to measure estradiol-'H. In the females, subjects 13 and 15, CRsaAs was 0.0007 and 0.0014, respectively.
In eight males, the mean CRBTBD was 0.0018 ±0.0002, and, in six females, the mean CRBB`m was 0.0005 + 0.0001 (Table II) . CRBBT3 was 0.001 in the two subjects, both males, in whom it could be measured directly.
[p]aB values for androgen conversion to estrogen.
In Tables III and IV (7) and stands for mean Ln of MCRE1 in liters/day per in. § 95% confidence limits appear in parentheses. (26) (27) (28) (29) (30) and The question as to whether there is any significant A'-androstenedione (11) . This, then, is evidence that conversion of the circulating androgens, A'-androstene-there is conversion of these androgens to estrogens, but dione and testosterone, to the estrogens, estrone and it is not conclusive evidence that these conversions con-17P-estradiol, has long been of interest. Studies in the tribute significantly to the circulating pool of free estropast, notably those of Leach, Maddock, Tokuyama, gens. It has been shown, directly for the interconversion Paulsen, and Nelson (10); West, Damast, Sarro, and between adrostenedione and testosterone (2, 4) and inPearson (9) ; and Givner, Bauld, Hale, Vogi, and Nilsen directly for the interconversion of estrone and estradiol (23) have shown that there is a rise in the urinary ex- (7, 8) , that the conversion of a precursor steroid to the cretion of estrogens after the administration of testos-urinary metabolite of a product steroid does not necesterone propionate to males and nonpregnant females. sarily contribute to the blood pool of ee product This suggested that testosterone could be converted to steroid. estrogens but did not rule out a stimulatory effect of Our results; however, obtained by infusing the radiotestosterone, or a metabolite, on estrogen synthesis. active precursor androgen and measuring the radioFrench, Baggett, Van Wyk, Talbert, Hubbard, John-activity in the free product estrogen show that the cirston, and Weaver (24) were not able to demonstrate any culating free androgens are converted to circulating conversion of radioactive testosterone to the urinary free estrogens. The fraction of androgen so converted metabolites of estradiol in indivduals with feminizing is not large, about 1% of the androstenedione entering testes. Since there is a defect in the peripheral utilizaton the blood de novo is converted to estrogen, and about of testosterone in these individuals (24) , this failure to 0.4% of the testosterone in males and less than 0.2% in note conversion is not, perhaps, applicable to normal females is converted to estradiol. Mean 5SE. § Antilog of the mean (95% confidence limits).
The free estrogens that we measure are converted from androgens in the tissues and then appear in the blood before irreversible metabolism. Our data do not, however, indicate in what tissues the conversions occur. Human fetal liver (31), human mammary carcinoma (32) , and rat liver and kidney (33) have all been shown capable of aromatizing androgens. It is also possible that the conversions represent aromatization of circulating androgens by adrenal or gonadal tissue. The data of MacDonald, Rombaut, and Siiteri (11) who found the fraction of radioactivity appearing in the urinary metabolites of estrogens after administration of radioactive androstenedione to be similar in normal, adrenalectomized, and castrated individuals makes this possibility less likely.
It has been shown that the placenta (34) aromatizes androstenedione somewhat more readily than testosterone, and it has been suggested that the aromatization of testosterone by placental microsomes occurs preferentially via androstenedione and 19-OH androstenedione (35) . Our data also suggest that androstenedione is aromatized more readily than testosterone. However, the fact that circulating androstenedione is converted to circulating estradiol to a lesser degree than is testosterone suggests that, as regards measurements in the peripheral blood, the aromatization of testosterone does not occur preferentially via androstenedione. In all likelihood, the peripheral aromatization reaction occurs largely via the respective 19-OH intermediates and the 17-hydroxy group is preserved. The fact that we were not able to demonstrate conversion of androstenedione to estradiol or testosterone to estrone in many individuals is no indication that such reactions did not occur; it means only that these particular conversions, as measured in blood, occurred in most instances at a level below our current ability to detect. In actual fact, as shown in Fig. 1 , the conversion of androstenedione to estradiol, and testosterone to estrone must occur, but, under the conditions used in our experiments, such conversions must be of a very low order.
For the conversion of androstenedione to estrone and testosterone to estradiol, whether measured directly as a conversion ratio, or calculated as a [P]BB value, the mean values in males were higher than the respective mean values in females. It would thus appear from measurements in blood that males are capable of greater peripheral aromatizati6n of androgens to estrogens than are females. Whether this is possibly due to greater enzyme activity or to differences in the concentrations of precursor and/or product in blood cannot be delineated further from our data.
One of the important aspects of a [P]BB value is that it can be used to estimate the amount of product formed from precursor if the blood production rate of precursor and product are known. As defined by Horton and Tait (2) and used by them and others (2, 19, 36, 37) , the blood production rate' (PB) is defined as that amount of a steroid entering the blood, de novo, per unit time. The amount of product formed from precursor will then be the blood production rate of precursor multiplied by the [P]BB value for precursor conversion to product. We did not directly measure the blood production rates for the androgens and estrogens in our study, but we can obtain an estimate of the androgen contribution to estrogen production from the mean data of Baird, Horton, Longcope, and Tait (36) for androgen and estrogen production rates, which were obtained by several groups in studies on individuals comparable with our subjects. In this manner, we estimate that in males at least half the estradiol entering the blood, de novo, arises as a result of conversion of testosterone to estradiol. Thus, even though the [p]BB"T is between -0.3 and 0.45% in the male, so much more testosterone (about 7 mg/day) is produced as compared with estradiol (about 40 /Lg/ day) that the contribution of testosterone (about [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] lAg/day) is highly significant. Our estimate that at least 50% of the estradiol arises from testosterone is in the same range as the earlier and more indirect estimates of Leach et al. (10) and Epstein, Raheja, Prow, and Morse (28) .
On the other hand, in normal, nonpregnant females, testosterone (200-300 Ag/day) and estradiol (100-300 Ag/day) are produced in somewhat similar amounts for a large part of the cycle, and [P]BBTE2 is only 0.16%, so that the contribution of testosterone to estradiol is insignificant.
In both males and females, the production of androstenedione is similar (about 3 mg/day) and is greater than the estimated PB of estrone (about 125-150 lAg/day). Therefore, even though the conversions of androstenedione to estrone are only about 1.5% in males and 0.7% in females, these contributions (about 30-50 ug/day) would appear to make up at least 20-30% of the estrone entering the blood per day de novo in both sexes.
The contribution of the androgens to the circulating estrogens, estrone and estradiol, in the male and estrone in the female would thus appear to be a highly significant source of these estrogens. The entire blood production rate of the estrogens, however, does not appear to result from these conversions. Whether the sources of the rest of the blood production rates are other precursors or direct secretion of the estrogens cannot be said from these data alone. However, since other precursors are unlikely (36, 37) , it would appear that in males and females there is direct secretion of both estrone and estradiol. Recently, Brenner, Hutchinson, Siiteri, and MacDonald (38) reported that in normal males the entire production rate of estrone and estradiol could be accounted for by conversion from androstenedione and testosterone. This is at variance with our conclusions noted above, and the disagreement possibly is due to differences in calculating production rates and interconversions of the estrogens, since Brenner et al. (38) used a combined blood and urinary approach (36) . Thus, they were equating an androgen blood production rate determined at a specific time of day with an estrogen production rate calculated from the integrated specific activity of urinary metabolites excreted over several days. In addition, the conversions of androstenedione to estradiol, 0.8%, and testosterone to estrone, 0.2%, as calculated from isotopic ratios of urinary metabolites, appear to be far higher than these particular conversions measured using the free steroid radioactivity in blood (0.0-0.1% for each). Thus, the use of data obtained from urinary metabolites may have slightly overestimated the contribution of the circulating androgens to the circulating estrogens.
Our mean values for the metabolic clearance rates of androstenedione and testosterone were similar to those reported previously by Bardin and Lipsett (19) and Southren, Gordon, Tochimoto, Pinzon, Lane, and Stypulkowski (39) . We found no difference for MCRA between males and females, and in both sexes MCRA was greater than MCRT. We also found, however, that MCRT was significantly greater in males than females. These differences in the clearance rates of MCRA and MCRT, and the greater MCRT in males than females were probably a reflection in large part of the greater plasma globulin binding of testosterone in females as compared with males, and in both sexes the greater plasma globulin binding of testosterone as compared with androstenedione (40, 41) . Similarly, the distribution coefficients between red cells and plasma for androstenedione and testosterone probably were another indication of the greater binding of testosterone, as compared with androstenedione, to a plasma globulin (42, 43) . Testosterone which is strongly bound to plasma globulins has a lower distribution coefficient than androstenedione which is weakly bound to plasma globulins. It has also been suggested for cortisol (44) and for estradiol in females (7) (36, 37) that the oxidative pathway is the more favored one, so far as these conversions are concerned.
